Stay updated with breaking news from Ikarian capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Cybin (NYSE:CYBN – Free Report) in a research report report published on Thursday, Benzinga reports. The brokerage currently has a $5.00 price objective on the stock. HC Wainwright also issued estimates for Cybin’s FY2029 earnings at $0.26 EPS. Cybin Stock Down 0.6 % NYSE:CYBN opened at […] ....
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Hunter Gillies sold 4,000 shares of the stock in a transaction on Friday, May 17th. The stock was sold at an average price of $21.08, for a total value of $84,320.00. Following the sale, the insider now owns 5,602 shares in the company, valued at approximately […] ....
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 10,000 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $21.58, for a total value of $215,800.00. The sale was disclosed in a document filed with the SEC, which can be […] ....
Wedbush reaffirmed their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $41.00 price target on the stock. Wedbush also issued estimates for Aerovate Therapeutics’ Q2 2024 earnings at ($0.71) EPS, Q3 2024 earnings at ($0.66) EPS, Q4 2024 earnings […] ....
Stifel Nicolaus restated their buy rating on shares of Nyxoah (NASDAQ:NYXH – Free Report) in a report published on Wednesday morning, Benzinga reports. The firm currently has a $27.00 target price on the stock. Several other analysts also recently weighed in on the company. HC Wainwright restated a buy rating and issued a $22.00 price […] ....